A simple strategy could make first-line antibiotics more effective against resistant bacteria
Researchers have identified a single, simple metric to inform medication regimen design that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens.
A computer simulation created by Hannah Meredith, a biomedical engineering graduate fellow at Duke University, revealed that a regimen based on a pathogen’s recovery time could eliminate an otherwise resistant strain of bacteria. In theory, a database of recovery times for bacterial and antibiotic combinations could allow first-line antibiotics to clear many resistant infections.
Meredith has already begun lab work to create such a database, and early tests are confirming her model’s predictions.
The study appears in PLOS Computational Biology on April 23, 2015.
“Bacteria are forming resistance to antibiotics faster than we can make new ones, so there is a real need to use the antibiotics that are already on the market more efficiently,” said Meredith. “We hope this research will help hospitals improve patient outcomes while also making our antibiotics last as long as possible.”
The computer simulation models the relationship between bacteria, antibiotics and a method of resistance called beta-lactamase—an enzyme that degrades beta-lactam antibiotics, one of the largest and most-used classes of antibiotics. Many beta-lactam antibiotics are currently disregarded out of concern for the infection being completely resistant to that type of antibiotic—even if the antibiotic appeared to be effective in the lab. The new model, however, reveals that the infection might be temporarily sensitive to the antibiotic before the beta-lactamase degrades the drug and allows the infection to recover.
“You can think of this as a race between the cells and the antibiotics,” said Lingchong You, the Paul Ruffin Scarborough Associate Professor of Biomedical Engineering at Duke and Meredith’s advisor. “Before their beta-lactamase degrades the antibiotics, the cells are still sensitive and can be killed. But the antibiotics degrade faster than the cell population declines, allowing some cells to survive and repopulate.”
When clinicians realize an infection is resistant, they often skip straight to some of the strongest antibiotics available. But the study indicates that if they instead changed the dosing frequency of first-line antibiotics such that each dose is delivered while the bacteria are weakened during their recovery period, some infections could be cleared without skipping to the last resort.
Doctors also need to be careful, however, not to wreck native populations of bacteria vital to human health. A database detailing the responses of different strains to different antibiotics could allow Meredith’s computer model to determine the most efficient regimen to keep total exposure to a minimum. It could also indicate if multiple doses would not work, letting clinicians know when it is time to call in the heavy artillery.
Read more: Finding New Life for First-Line Antibiotics
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Animal Antibiotics and Antimicrobials Market outlook, Future Scope, Demands and Projected Industry Growths to 2022on May 24, 2020 at 11:19 pm
Latest update on Animal Antibiotics and Antimicrobials Market Analysis report published with an extensive market research, Animal Antibiotics and Antimicrobials market growth analysis and Projection ...
- US farms are using MORE antibiotics despite warnings that overuse will spread superbugson May 23, 2020 at 3:03 pm
Figures obtained by The Mail on Sunday reveal that the sale of antibiotics to American farms jumped from 5,559 tons in 2017 to 6,036 tons in 2018 - a 9 per cent rise (file photo).
- Insight into mechanism of treatment-resistant gonorrhea sets stage for new antibioticson May 22, 2020 at 9:10 am
Medical University of South Carolina researchers investigated the effects of mutations altering the structure of an essential protein in an antibiotic-resistant strain of Neisseria gonorrhoeae. They ...
- Can Antibiotics Make Your Birth Control Less Effective?on May 22, 2020 at 5:53 am
Do antibiotics affect birth control? Ob-gyns explain whether antibiotics affect birth control, which antibiotics can reduce the effectiveness, and which methods of birth control can be affected. They ...
- Global Antibiotics Market (2020 to 2027) - COVID-19 Impact and Global Analysis by Drug Class, Action Mechanism and Geography - ResearchAndMarkets.comon May 21, 2020 at 3:37 am
The antibiotics was valued at US$ 43,348.38 million in 2019 and is projected to reach US$ 56,351.33 million by 2027; it is expected to grow at a CAGR of 3.6% from 2020 to 2027. “Antibiotics Market ...
- Global Animal Feed Additives Market Outlook, 2020-2025 - Ban on Antibiotics Boosts Demand for Amino Acids as Feed Additiveson May 20, 2020 at 4:08 am
Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The Animal Feed Additives market worldwide is projected to grow by US$6 Billion, driven by a ...
- No, COVID-19 won’t respond to antibiotics, despite findings from new autopsieson May 19, 2020 at 12:47 pm
Autopsies prove that COVID-19 is” a blood clot, not pneumonia, “and ought to be fought with antibiotics” and the whole world has been wrong in treating the “so-called” pandemic. Viruses do not respond ...
- Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer’s transgenic miceon May 18, 2020 at 2:15 am
In preceding efforts, we demonstrated that antibiotic (ABX) cocktail-mediated perturbations of the gut microbiome in two independent transgenic lines, termed APP SWE /PS1 ΔE9 and ...
- Community knowledge about antibiotics key to fighting against 'superbug' threaton May 14, 2020 at 10:16 pm
With predictions that drug-resistant ‘superbugs’ could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics.
- Global Antibiotics Partnering Terms and Agreements: 2010 to 2020 - ResearchAndMarkets.comon May 14, 2020 at 5:39 am
This report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed ...
via Bing News